
|Articles|November 15, 2003
FDA to allow inserts for keratoconus patients
Des Plaines, IL-Micro-thin prescription inserts (Intacs, Addition Technology Inc.) may be used to reduce or eliminate myopia and astigmatism in patients with keratoconus for whom restoration of functional vision is no longer possible with contact lenses or glasses, under a new designation by the FDA.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
2
TECNIS PureSee IOL launches in US following FDA approval for cataract surgery
3
Dompé initiates phase 3 Orunea trial of cenegermin-bkbj in PCED
4
Beyond the basics: John Berdahl, MD, on AI-driven IOL planning, PCO prevention, and lessons from the mission field
5





















